Bruker Corporation (BRKR) recently launched the LUMOS II ILIM, a quantum cascade laser (QCL)-based infrared imaging microscope. The breakthrough innovation sets new performance standards, enabling pharma and life science researchers to capture ultrafast IR images of expansive areas with enhanced spatial resolution.The latest development is expected to strongly boost Bruker’s CALID segment.BRKR Stock’s Likely Trend Following the NewsSince the announcement on Jan. 8, shares of Bruker have gained 3.3%, finishi ...